Personal genome medicine : the legal and regulatory transformation of U.S. medicine / Michael J. Malinowski, Louisiana State University.
Publisher: Cambridge, United Kingdom ; New York, NY : Cambridge University Press, ©2023Description: 464 pages cmContent type:- text
- unmediated
- volume
- 9781009293327
- KF3827.G4 M35 2023
BOOKS
| Current library | Home library | Call number | Status | Barcode | |
|---|---|---|---|---|---|
| Alfaisal University On Shelf | Alfaisal University On Shelf | KF3827.G4 M35 2023 (Browse shelf(Opens below)) | Available | AU00000000020263 |
Includes bibliographical references and index.
Prologue. Revolution, transition, and transformation -- Medical profession sovereignty to protect and promote the science and evidence base of US medicine -- US integration of government, academia, and industry : a catalyst for science-technology revolutions -- The proliferation of US direct-to-consumer (DTC) and direct-to-physician (DTP) biopharmaceutical marketing -- The evolution of consumer genetic testing services from Oncormed, Inc. to 23andMe Holding Co. -- Vulnerability of the science and evidence base of US medicine -- A warning label for commercial direct-to-consumer (DTC) genetics -- Protecting and promoting the evidentiary-science base of personal genome medicine (PGM) epilogue. the personal genome future of US medicine.
"The United States' decentralized, largely privatized, and commerce-driven healthcare system is undergoing a shift to personal genome medicine. This change is charged by ongoing progress in biotech and genomic research and development. This book draws from U.S. medicine's past and present to address its emerging personal genome medicine future"--